Johnson & Johnson
JNJNYSE
$265.04
Last price · USD
- Market cap
- $643.9B
- P/E
- 24.0x
- EV / EBITDA
- 16.4x
- P/S
- 6.8x
- FCF yield
- 3.1%
- Div. yield
- 1.92%
Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.
Johnson & Johnson key metrics & ratios
Annual · USD millions except per-share data · 36 lines
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | CAGR | |
|---|---|---|---|---|---|---|---|
| Growth (year over year) | |||||||
| Revenue growth | 6.0% | 4.3% | 6.5% | 1.6% | — | — | |
| Operating income growth | 15.6% | -5.4% | 11.4% | 0.3% | — | — | |
| Net income growth | 90.6% | -60.0% | 95.9% | -14.1% | — | — | |
| EPS (diluted) growth | 90.5% | -57.8% | 103.9% | -13.8% | — | — | |
| Free cash flow growth | -0.7% | 8.7% | 6.2% | -13.0% | — | — | |
| Margins | |||||||
| Gross margin | 67.9% | 69.1% | 68.8% | 69.3% | 70.3% | — | |
| Operating margin | 27.2% | 24.9% | 27.5% | 26.3% | 26.6% | — | |
| EBITDA margin | 43.6% | 27.9% | 27.4% | 33.3% | 34.0% | — | |
| Net margin | 28.5% | 15.8% | 41.3% | 22.4% | 26.5% | — | |
| FCF margin | 20.9% | 22.3% | 21.4% | 21.5% | 25.1% | — | |
| Returns on capital | |||||||
| Return on equity | 32.9% | 19.7% | 51.1% | 23.4% | 28.2% | — | |
| Return on assets | 13.5% | 7.8% | 21.0% | 9.6% | 11.5% | — | |
| Return on invested capital | 19.2% | 22.2% | 27.2% | 17.2% | 20.8% | — | |
| Leverage & liquidity | |||||||
| Debt / equity | 0.59x | 0.51x | 0.43x | 0.52x | 0.46x | — | |
| Net debt / EBITDA | 0.69x | 0.51x | 0.32x | 1.01x | 0.72x | — | |
| Current ratio | 1.03x | 1.11x | 1.16x | 0.99x | 1.35x | — | |
| Interest coverage | 26.36x | 29.34x | 30.32x | 76.13x | 114.44x | — | |
| Profitability & operating | |||||||
| EBIT | 33,552 | 17,442 | 15,834 | 19,635 | 19,361 | +14.7% | |
| EBITDA | 41,055 | 24,781 | 23,320 | 26,605 | 26,751 | +11.3% | |
| Operating income | 25,596 | 22,149 | 23,409 | 21,013 | 20,943 | +5.1% | |
| Income before tax | 32,581 | 16,687 | 15,062 | 19,359 | 19,178 | +14.2% | |
| Net income | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 | +6.4% | |
| Earnings per share | |||||||
| EPS (basic) | $11.03 | $5.84 | $13.88 | $6.83 | $7.93 | +8.6% | |
| EPS (diluted) | $11.03 | $5.79 | $13.72 | $6.73 | $7.81 | +9.0% | |
| Share count (millions) | |||||||
| Weighted avg shares outstanding | 2,429 | 2,407 | 2,534 | 2,614 | 2,629 | -2.0% | |
| Weighted avg shares outstanding (diluted) | 2,429 | 2,429 | 2,560 | 2,664 | 2,674 | -2.4% | |
| Balance sheet highlights | |||||||
| Net debt | 28,224 | 12,529 | 7,473 | 26,753 | 19,264 | +10.0% | |
| Total debt | 47,933 | 36,634 | 29,332 | 39,642 | 33,751 | +9.2% | |
| Total investments | 393 | 417 | 1,068 | 9,392 | 17,121 | -61.1% | |
| Total stockholders' equity | 81,544 | 71,490 | 68,774 | 76,804 | 74,023 | +2.4% | |
| Total assets | 199,210 | 180,104 | 167,558 | 187,378 | 182,018 | +2.3% | |
| Cash flow highlights | |||||||
| Free cash flow | 19,698 | 19,842 | 18,248 | 17,185 | 19,758 | -0.1% | |
| Operating cash flow | 24,530 | 24,266 | 22,791 | 21,194 | 23,410 | +1.2% | |
| Capital expenditure | (4,832) | (4,424) | (4,543) | (4,009) | (3,652) | — | |
| Net cash from operating activities | 24,530 | 24,266 | 22,791 | 21,194 | 23,410 | +1.2% | |
| Additional fields | |||||||
| Accrued Expenses | 27,718 | 26,129 | 26,213 | 24,298 | 25,707 | +1.9% | |